Francisco Javier López-Delgado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francisco Javier López-Delgado has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Juan Jose Diaz Mochon
Department of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Cartuja Campus, Universidad de Granada, Granada, Spain; Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Granada, Spain; Instituto de Investigación Biosanitaria de Granada, Granada, Spain, Spain
12 shared publications - Salvatore Pernagallo
Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy, Spain
11 shared publications - Rosario Maria Sanchez-Martin
University of Granada
9 shared publications Juan J. Guardia-Monteagudo
DESTINA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS), Avenida de la Innovación 1, Edificio BIC, Armilla, 18016, Granada, Spain
7 shared publicationsMario Antonio Fara
6 shared publications- Mavys Tabraue-Chávez
DESTINA Genomica S.L. Parque Tecnológico Ciencias de la Salud (PTS) Granada Spain
6 shared publications
Latest Publications
- Open Access
- 17 November 2025
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 92 (2) , 612-618
Short communication: Dynamic chemical labelling allows the measurement of the paracetamol toxicity biomarker microRNA‐122 in hospital clinical laboratories
MicroRNA‐122 (miR‐122) is a sensitive biomarker for paracetamol‐induced liver injury. This study assessed the diagnostic performance of dynamic chemical labelling (DCL) combined with an immunoassay platform to quantify miR‐122 in human serum, as a proof‐of‐concept for hospital use. This study used serum samples from 19 healthy individuals and 19 patients with paracetamol drug‐induced liver injury (DILI) collected in previous studies. miR‐122 was labelled with a biotinylated SMART‐Base and quantified using a multiplex, bead‐based, fluorescence detection system. The median miR‐122 concentration was significantly elevated at 233.4 pg/mL (IQR: 74.5–363.4) compared to 15.2 pg/mL (IQR: 9.4–24) in the control group. The Mann–Whitney U test showed significant group differences ( p < 0.0001). ROC analysis yielded an area under the curve (AUC) of 0.96, with a 29.7 pg/mL cut‐off providing 92.6% sensitivity (95% CI: 76.6%–98.7%) and 89.4% specificity (95% CI: 68.6%–98.1%). miR‐122 moderately correlated with ALT ( r = 0.56, p = 0.03). DCL with fluorescence detection is a promising clinical tool for miR‐122 quantification.
- 17 November 2025
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 92 (2) , 612-618
Open AccessShort communication: Dynamic chemical labelling allows the measurement of the paracetamol toxicity biomarker microRNA‐122 in hospital clinical laboratories
MicroRNA‐122 (miR‐122) is a sensitive biomarker for paracetamol‐induced liver injury. This study assessed the diagnostic performance of dynamic chemical labelling (DCL) combined with an immunoassay platform to quantify miR‐122 in human serum, as a proof‐of‐concept for hospital use. This study used serum samples from 19 healthy individuals and 19 patients with paracetamol drug‐induced liver injury (DILI) collected in previous studies. miR‐122 was labelled with a biotinylated SMART‐Base and quantified using a multiplex, bead‐based, fluorescence detection system. The median miR‐122 concentration was significantly elevated at 233.4 pg/mL (IQR: 74.5–363.4) compared to 15.2 pg/mL (IQR: 9.4–24) in the control group. The Mann–Whitney U test showed significant group differences ( p < 0.0001). ROC analysis yielded an area under the curve (AUC) of 0.96, with a 29.7 pg/mL cut‐off providing 92.6% sensitivity (95% CI: 76.6%–98.7%) and 89.4% specificity (95% CI: 68.6%–98.1%). miR‐122 moderately correlated with ALT ( r = 0.56, p = 0.03). DCL with fluorescence detection is a promising clinical tool for miR‐122 quantification.
- Open Access
Tracker Nanocatalyst for Screening of Intracellular Copper‐Catalyzed Azide‐Alkyne Cycloadditions
Intracellular copper‐catalyzed azide‐alkyne cycloaddition (CuAAC) offers immense potential for bioorthogonal chemistry, but its application is severely hindered by copper toxicity and the challenge of controlling catalysis within the complex cellular environment. Heterogeneous copper catalysts can reduce toxicity by minimizing free copper exposure and enabling localized activity, yet optimizing their performance in situ within living cells remains a significant hurdle. Here, the development of a novel dual‐functional nanocatalyst, Cu@BTTAA‐Cy5‐NPs, that combines robust heterogeneous CuAAC catalytic activity with intrinsic fluorescence tracking is reported. The successful synthesis and characterization of these monodispersed nanoparticles is demonstrated, confirming efficient copper loading stabilized by BTTAA and the nanoparticle matrix, and critically, the retention of Cy5 fluorescence for tracking. This unique dual functionality allows for real‐time monitoring of nanoparticle localization and correlation with catalytic product formation via distinct fluorescence channels, enabling, for the first time to our knowledge, comprehensive in situ screening and optimization of CuAAC reaction conditions directly within living cells using fluorescence feedback. The nanoparticles exhibit excellent biocompatibility and cellular uptake, showing no significant toxicity, apoptosis, or oxidative stress at active concentrations.
Open AccessTracker Nanocatalyst for Screening of Intracellular Copper‐Catalyzed Azide‐Alkyne Cycloadditions
Intracellular copper‐catalyzed azide‐alkyne cycloaddition (CuAAC) offers immense potential for bioorthogonal chemistry, but its application is severely hindered by copper toxicity and the challenge of controlling catalysis within the complex cellular environment. Heterogeneous copper catalysts can reduce toxicity by minimizing free copper exposure and enabling localized activity, yet optimizing their performance in situ within living cells remains a significant hurdle. Here, the development of a novel dual‐functional nanocatalyst, Cu@BTTAA‐Cy5‐NPs, that combines robust heterogeneous CuAAC catalytic activity with intrinsic fluorescence tracking is reported. The successful synthesis and characterization of these monodispersed nanoparticles is demonstrated, confirming efficient copper loading stabilized by BTTAA and the nanoparticle matrix, and critically, the retention of Cy5 fluorescence for tracking. This unique dual functionality allows for real‐time monitoring of nanoparticle localization and correlation with catalytic product formation via distinct fluorescence channels, enabling, for the first time to our knowledge, comprehensive in situ screening and optimization of CuAAC reaction conditions directly within living cells using fluorescence feedback. The nanoparticles exhibit excellent biocompatibility and cellular uptake, showing no significant toxicity, apoptosis, or oxidative stress at active concentrations.
- Open Access
- 23 July 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (8) , 1088
Carbohydrate-Based Chiral Ligands for the Enantioselective Addition of Diethylzinc to Aldehydes
Background: Carbohydrate-derived chiral ligands are promising tools in asymmetric catalysis due to their structural diversity, chirality, and availability. However, ligands based on galactose or sorbose have been scarcely explored in the enantioselective addition of dialkylzinc reagents to aldehydes. Methods: A series of chiral diols and β-amino alcohols was synthesized from methyl D-glucopyranoside, methyl D-galactopyranoside, and D-fructose. These ligands were tested in the titanium tetraisopropoxide-promoted enantioselective addition of diethylzinc to aromatic and aliphatic aldehydes. Results: Several ligands, particularly those with a D-fructopyranose backbone, exhibited excellent catalytic activity, with conversion rates up to 100% and enantioselectivities up to 96% ee. Notably, this study reports for the first time the use of β-amino alcohols derived from fructose and sorbose in this transformation. Conclusions: Carbohydrate-based ligands represent effective, inexpensive, and structurally versatile scaffolds for developing highly enantioselective catalysts, expanding the utility of sugars in asymmetric organometallic reactions.
- 23 July 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (8) , 1088
Open AccessCarbohydrate-Based Chiral Ligands for the Enantioselective Addition of Diethylzinc to Aldehydes
Background: Carbohydrate-derived chiral ligands are promising tools in asymmetric catalysis due to their structural diversity, chirality, and availability. However, ligands based on galactose or sorbose have been scarcely explored in the enantioselective addition of dialkylzinc reagents to aldehydes. Methods: A series of chiral diols and β-amino alcohols was synthesized from methyl D-glucopyranoside, methyl D-galactopyranoside, and D-fructose. These ligands were tested in the titanium tetraisopropoxide-promoted enantioselective addition of diethylzinc to aromatic and aliphatic aldehydes. Results: Several ligands, particularly those with a D-fructopyranose backbone, exhibited excellent catalytic activity, with conversion rates up to 100% and enantioselectivities up to 96% ee. Notably, this study reports for the first time the use of β-amino alcohols derived from fructose and sorbose in this transformation. Conclusions: Carbohydrate-based ligands represent effective, inexpensive, and structurally versatile scaffolds for developing highly enantioselective catalysts, expanding the utility of sugars in asymmetric organometallic reactions.
- Open Access
- 10 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Click Chemistry-Driven Dual Nanosystem for miR-122 Detection with Single-Base Specificity from Tumour Cells
MicroRNAs (miRNAs) are considered potential biomarkers due to their specific expression patterns in tissues and their changes in expression under pathological conditions. MicroRNA-122 (miR-122) is a vertebrate-specific miRNA known for its high expression in the liver, where it plays a role in hepatic metabolism, liver development and cellular differentiation. Dysregulation of miR-122 has been found in pathological conditions such as hepatocellular carcinoma or drug-induced liver injury (DILI). Currently, miRNA detection faces challenges such as improving point-of-care efficiency, obtaining direct results and accurately identifying miRNA isoforms. Overcoming these challenges is essential to improve the clinical efficacy of miR-122 detection as a diagnostic and prognostic biomarker in liver-related diseases. In this study, we present a click chemistry driven dual nanosystem designed for single-base specific miR-122 detection using a flow cytometer as the reading platform. Using the dual nanosystem, we analysed miR-122 expression in various tumour cell lines with specificity and robustness, showing a high correlation with results obtained from a TaqMan assay. We also detected miR-122 using a serum matrix and identified four single nucleotide variations at a specific position within the miR-122 sequence. Our approach involves a fully bioorthogonal strategy and includes signal amplification using two types of different nanoparticles together with the high affinity of peptide nucleic acid probes. The chemistry used in this dual nanosystem offers remarkable versatility and provides a promising opportunity to pioneer enzyme-free nanoparticle-based strategies based on click chemistry and bioorthogonality miRNA detection and isomiR studies, thus advancing the field of molecular diagnostics.
- 10 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessClick Chemistry-Driven Dual Nanosystem for miR-122 Detection with Single-Base Specificity from Tumour Cells
MicroRNAs (miRNAs) are considered potential biomarkers due to their specific expression patterns in tissues and their changes in expression under pathological conditions. MicroRNA-122 (miR-122) is a vertebrate-specific miRNA known for its high expression in the liver, where it plays a role in hepatic metabolism, liver development and cellular differentiation. Dysregulation of miR-122 has been found in pathological conditions such as hepatocellular carcinoma or drug-induced liver injury (DILI). Currently, miRNA detection faces challenges such as improving point-of-care efficiency, obtaining direct results and accurately identifying miRNA isoforms. Overcoming these challenges is essential to improve the clinical efficacy of miR-122 detection as a diagnostic and prognostic biomarker in liver-related diseases. In this study, we present a click chemistry driven dual nanosystem designed for single-base specific miR-122 detection using a flow cytometer as the reading platform. Using the dual nanosystem, we analysed miR-122 expression in various tumour cell lines with specificity and robustness, showing a high correlation with results obtained from a TaqMan assay. We also detected miR-122 using a serum matrix and identified four single nucleotide variations at a specific position within the miR-122 sequence. Our approach involves a fully bioorthogonal strategy and includes signal amplification using two types of different nanoparticles together with the high affinity of peptide nucleic acid probes. The chemistry used in this dual nanosystem offers remarkable versatility and provides a promising opportunity to pioneer enzyme-free nanoparticle-based strategies based on click chemistry and bioorthogonality miRNA detection and isomiR studies, thus advancing the field of molecular diagnostics.
- Open Access
- 14 June 2024
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 417
Multiplexed MicroRNA biomarker detection by bridging lifetime filtering imaging and dynamic chemical labeling
- 14 June 2024
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 417
Open AccessMultiplexed MicroRNA biomarker detection by bridging lifetime filtering imaging and dynamic chemical labeling
- Open Access
- 1 April 2024
- Published by Elsevier in SSRN Electronic Journal
Multiplexed Microrna Biomarker Detection by Bridging Lifetime Filtering Imaging and Dynamic Chemistry Labeling
MicroRNAs (miRs) have emerged as promising biomarkers for early disease diagnosis and personalized treatment monitoring. However, their clinical utility has been hampered by technical limitations. Dynamic chemical labeling (DCL) based on capturing abasic PNA probes and reactive nucleobases, known as SMART bases, is a PCR-free approach that has proven very useful for the direct interrogation of circulating miRs. In this work, we expand the palette of tools available for the detection of DCL miR by synthesizing a new SMART nucleobase called SMART-C-Eu. This nucleobase contains a stable lanthanide cryptate. Using this SMART-C-Eu base and time-gated (TG) luminescence imaging, we successfully detect and quantify miR-122-5p in human serum samples. miR-122-5p is a well-known biomarker for drug-induced liver injury. Through a bead-counting analysis approach, statistical robustness is improved and miR-122-5p concentrations are detected in the nanomolar range. Furthermore, we extend this approach to multiplexed detection of three different miRs (miR-371a-3p, miR-451a-5p, and miR-122-5p) using spectral and temporal filtering. Importantly, we designed a user-independent multiplexed analysis using machine learning algorithms for automatic bead classification. Although the sensitivity of this technique must be further improved to detect miRs at lower concentrations, the method represents a significant advancement in miR analysis by combining ML segmentation using lifetime and intensity images. In addition, the technique offers multiplexing capabilities and the potential for automation, paving the way for more accurate and robust clinical applications in the future.
- 1 April 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessMultiplexed Microrna Biomarker Detection by Bridging Lifetime Filtering Imaging and Dynamic Chemistry Labeling
MicroRNAs (miRs) have emerged as promising biomarkers for early disease diagnosis and personalized treatment monitoring. However, their clinical utility has been hampered by technical limitations. Dynamic chemical labeling (DCL) based on capturing abasic PNA probes and reactive nucleobases, known as SMART bases, is a PCR-free approach that has proven very useful for the direct interrogation of circulating miRs. In this work, we expand the palette of tools available for the detection of DCL miR by synthesizing a new SMART nucleobase called SMART-C-Eu. This nucleobase contains a stable lanthanide cryptate. Using this SMART-C-Eu base and time-gated (TG) luminescence imaging, we successfully detect and quantify miR-122-5p in human serum samples. miR-122-5p is a well-known biomarker for drug-induced liver injury. Through a bead-counting analysis approach, statistical robustness is improved and miR-122-5p concentrations are detected in the nanomolar range. Furthermore, we extend this approach to multiplexed detection of three different miRs (miR-371a-3p, miR-451a-5p, and miR-122-5p) using spectral and temporal filtering. Importantly, we designed a user-independent multiplexed analysis using machine learning algorithms for automatic bead classification. Although the sensitivity of this technique must be further improved to detect miRs at lower concentrations, the method represents a significant advancement in miR analysis by combining ML segmentation using lifetime and intensity images. In addition, the technique offers multiplexing capabilities and the potential for automation, paving the way for more accurate and robust clinical applications in the future.
- Open Access
- 30 March 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 230, 115268
SARS-CoV-2 viral RNA detection using the novel CoVradar device associated with the CoVreader smartphone app
- 30 March 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 230, 115268
Open AccessSARS-CoV-2 viral RNA detection using the novel CoVradar device associated with the CoVreader smartphone app
- Open Access
- 29 November 2022
- Published by Elsevier in SSRN Electronic Journal
SARS-CoV-2 Viral RNA Detection Using the Novel Covradar Device Associated with the CoVreader Smartphone App
COVID-19 pandemic has pointed out the strong need to continue promoting the development of innovative approaches for the rapid, safe handling and accurate molecular diagnosis of SARS-CoV-2 infection. In this work, we have developed CoVradar, a novel colourimetric molecular detection system that integrates nucleic acid analysis by dynamic chemistry labelling (DCL) technology with the Spin-Tube devices allowing reverse dot-blot hybridization in an array format to detect SARS-CoV-2 RNA within saliva specimens. The assay is designed so that ten regions per RNA copy act as templates to amplify the signal generated through a DCL reaction. The sequences are captured by abasic peptide nucleic acids (DGL-Probes) immobilised onto nylon membranes with a specific spot pattern. Biotinylated SMART-Bases are used for the labelling of duplexes formed upon the capture of complementary ssRNA fragment sequences that act as templates. Signals are then generated by the recognition of the biotin via streptavidin alkaline phosphatase and incubation with a chromogenic substrate which generates a blue precipitate. CoVradar’s results are automatically interpreted by CoVreader, a dedicated smartphone-based Image Processing System (IPS) capable of imaging and analysing the spot pattern developed to record and share results by mobile phone. The combination of CoVradar and CoVreader delivers a unique molecular assay capable of detecting SARS-CoV-2 viral RNA with single base specificity. This represents an innovative solution providing benefits in terms of time, cost, and simplicity, all of which are crucial for the diagnosis of COVID-19 but also in time, a repertoire of assays for other infectious diseases.
- 29 November 2022
- Published by Elsevier in SSRN Electronic Journal
Open AccessSARS-CoV-2 Viral RNA Detection Using the Novel Covradar Device Associated with the CoVreader Smartphone App
COVID-19 pandemic has pointed out the strong need to continue promoting the development of innovative approaches for the rapid, safe handling and accurate molecular diagnosis of SARS-CoV-2 infection. In this work, we have developed CoVradar, a novel colourimetric molecular detection system that integrates nucleic acid analysis by dynamic chemistry labelling (DCL) technology with the Spin-Tube devices allowing reverse dot-blot hybridization in an array format to detect SARS-CoV-2 RNA within saliva specimens. The assay is designed so that ten regions per RNA copy act as templates to amplify the signal generated through a DCL reaction. The sequences are captured by abasic peptide nucleic acids (DGL-Probes) immobilised onto nylon membranes with a specific spot pattern. Biotinylated SMART-Bases are used for the labelling of duplexes formed upon the capture of complementary ssRNA fragment sequences that act as templates. Signals are then generated by the recognition of the biotin via streptavidin alkaline phosphatase and incubation with a chromogenic substrate which generates a blue precipitate. CoVradar’s results are automatically interpreted by CoVreader, a dedicated smartphone-based Image Processing System (IPS) capable of imaging and analysing the spot pattern developed to record and share results by mobile phone. The combination of CoVradar and CoVreader delivers a unique molecular assay capable of detecting SARS-CoV-2 viral RNA with single base specificity. This represents an innovative solution providing benefits in terms of time, cost, and simplicity, all of which are crucial for the diagnosis of COVID-19 but also in time, a repertoire of assays for other infectious diseases.
- 6 October 2022
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 219, 114770
Direct detection of alpha satellite DNA with single-base resolution by using abasic Peptide Nucleic Acids and Fluorescent in situ Hybridization
- 6 October 2022
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 219, 114770
Direct detection of alpha satellite DNA with single-base resolution by using abasic Peptide Nucleic Acids and Fluorescent in situ Hybridization